anti-Borrelia burgdorferi antibody product blogThe Borrelia burgdorferi n/a (Catalog #MBS535167) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Borrelia burgdorferi antibody reacts with Borrelia burgdorferi and may cross-react with other species as described in the data sheet. MyBioSource\'s Borrelia burgdorferi can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunohistochemistry (IHC), Western Blot (WB). Researchers should empirically determine the suitability of the Borrelia burgdorferi n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Rabbit polyclonal Borrelia burgdorferi antibody.
Biological Significance: Borrelia burgdorferi is a species of Gram negative bacteria of the spirochete class of the genus Borrelia. B. burgdorferi is predominant in North America, but also exists in Europe, and is the agent of Lyme disease. Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Immunogen: Borrelia burgdorferi antibody was raised in rabbit using a whole cell preparation from Borrelia burgdorferi as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Borrelia burgdorferi are readily searchable from our website. Different antibodies against the same target such as Borrelia burgdorferi may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.